SOW
KZR

State of Wyoming’s Kezar Life Sciences KZR Stock Holding History

State of Wyoming’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-220
Closed -$36K – 2022
2022
Q1 		$36K Buy
220
+7
+3% +$1K 0.02% 1230
2021
Q4 		$36K Buy
213
+12
+6% +$1.35K 0.02% 1258
2021
Q3 		$17K Buy
201
+25
+14% +$1.66K 0.01% 967
2021
Q2 		$10K Buy
+176
New +$9.99K 0.01% 1013

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State of Wyoming's KZR Position: Q2 2022 in Review

State of Wyoming sold out of Kezar Life Sciences (KZR) in Q2 2022, closing a stake of 220 shares — an estimated $36K sold.

State of Wyoming first reported a position in KZR in Q2 2021 and held it in 4 quarters. The position peaked at $36K in Q1 2022. 127 funds tracked by Wall St. Rank hold KZR as of Q2 2022.

  • State of Wyoming reported no remaining Kezar Life Sciences position as of Q2 2022 after selling out during the quarter.
  • State of Wyoming sold 220 Kezar Life Sciences shares in Q2 2022, an estimated $36K.
  • State of Wyoming first reported a position in Kezar Life Sciences in Q2 2021 and held it in 4 quarters.
  • State of Wyoming's Kezar Life Sciences position peaked at $36K in Q1 2022.
  • 127 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2022.

Based on State of Wyoming's 13F filing for Q2 2022, filed 15 Aug 2022.